Related Experiment Videos

The use of imipenem-cilastatin in neonatal meningitis caused by Citrobacter diversus

Y Haimi-Cohen1, J Amir, A Weinstock

  • 1Department of Pediatrics, Golda Medical Center, Hasharon Hospital, Sackler School of Medicine, Tel Aviv University, Petach Tiqva, Israel.

Insights

Citrobacter diversus causes severe infant meningitis and brain abscesses. Imipenem-cilastatin offers a successful treatment option when standard therapies fail.

Area of Science:

  • Infectious Diseases
  • Pediatric Neurology
  • Microbiology

Background:

  • Citrobacter diversus is a significant pathogen causing severe meningitis in neonates and infants.
  • This bacterium is uniquely associated with brain abscess formation, contributing to poor patient outcomes.

Observation:

  • Standard treatment regimens, including third-generation cephalosporins, aminoglycosides, and trimethoprim-sulfamethoxazole, often yield disappointing results for C. diversus meningitis.
  • The development of brain abscesses complicates the management and prognosis of C. diversus meningitis.

Findings:

  • This study reports the successful use of imipenem-cilastatin in treating C. diversus meningitis.
  • Imipenem-cilastatin effectively managed cases complicated by brain abscesses, demonstrating its therapeutic potential.

Implications:

  • Imipenem-cilastatin represents a promising alternative therapeutic strategy for C. diversus meningitis, particularly when complicated by brain abscesses.
  • This finding may guide clinical decision-making for challenging pediatric meningitis cases caused by this pathogen.

Related Concept Videos